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Abstract
Capsule production is common among bacterial species, but relatively rare in eukaryotic microorganisms. Members of the
fungal Cryptococcus genus are known to produce capsules, which are major determinants of virulence in the highly
pathogenic species Cryptococcus neoformans and Cryptococcus gattii. Although the lack of virulence of many species of the
Cryptococcus genus can be explained solely by the lack of mammalian thermotolerance, it is uncertain whether the capsules
from these organisms are comparable to those of the pathogenic cryptococci. In this study, we compared the characteristic
of the capsule from the non-pathogenic environmental yeast Cryptococcus liquefaciens with that of C. neoformans.
Microscopic observations revealed that C. liquefaciens has a capsule visible in India ink preparations that was also efficiently
labeled by three antibodies generated to specific C. neoformans capsular antigens. Capsular polysaccharides of C.
liquefaciens were incorporated onto the cell surface of acapsular C. neoformans mutant cells. Polysaccharide composition
determinations in combination with confocal microscopy revealed that C. liquefaciens capsule consisted of mannose, xylose,
glucose, glucuronic acid, galactose and N-acetylglucosamine. Physical chemical analysis of the C. liquefaciens
polysaccharides in comparison with C. neoformans samples revealed significant differences in viscosity, elastic properties
and macromolecular structure parameters of polysaccharide solutions such as rigidity, effective diameter, zeta potential and
molecular mass, which nevertheless appeared to be characteristics of linear polysaccharides that also comprise capsular
polysaccharide of C. neoformans. The environmental yeast, however, showed enhanced susceptibility to the antimicrobial
activity of the environmental phagocytes, suggesting that the C. liquefaciens capsular components are insufficient in
protecting yeast cells against killing by amoeba. These results suggest that capsular structures in pathogenic Cryptococcus
species and environmental species share similar features, but also manifest significant difference that could influence their
potential to virulence.
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Introduction
Species belonging to the Cryptococcus genus are widely distributed
in nature. Cryptococcus spp. can be isolated from various environ-
mental sources such as air, soil, bird excreta, water, animals and
decomposing wood [1]. Within the genus, only a few species are
considered medically important and these appear to have different
characteristics that confer virulence [2]. The species mainly re-
sponsible for disease in man and animals are Cryptococcus neoformans
and Cryptococcus gattii [3]. However, in recent years there has been
an increased incidence of infections caused by other species, such
as Cryptococcus laurentii and Cryptococcus albidus, which together are
responsible for 80% of non-neoformans and non-gattii cryptococcosis
cases [4–7]. Understanding the characteristics that separate the
pathogenic and non-pathogenic cryptococcal species is important
for ascertaining the virulence potential of various members of
this genus. Such insights may be important is anticipating the
emergence of new virulent fungi as it has been hypothesized that
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29561climate warming promotes increased thermotolerance for fungal
species [8] and that mammalian temperatures are optimally fit for
resisting fungal pathogens [9].
C. neoformans and C. gattii possess a variety of well characterized
virulence factors, such as polysaccharide (PS) capsule formation,
melanin production and growth at 37uC. However, capsules are
not limited to these pathogenic species as they are common in
the Cryptococcus genus. Until now, little work has been done to
understand whether the capsular structures of pathogenic and
non-pathogenic cryptococcal species are comparable in function
and in their virulence potential. For C. neoformans and C. gattii, the
capsule is known to have protean functions in virulence ranging
from protecting the fungal cell against host antimicrobial
mechanisms to interfering with immune responses [10–14]. There
is no data assessing whether capsules from other members of
the Cryptococcus genus posses similar properties. This question is
important for efforts to understand the origin of virulence and the
characteristics that separate pathogenic and non-pathogenic
members of this genus.
Capsular PS complexity in C. neoformans has been extensively
study [15–18]. GXM is composed of combinations of seven
structural motifs that differ in the degree of acetylation in mannose
residues [19–22]. Generating capsules that vary in the ratio of
these residues provides an enormous combinatorial diversity such
that an infinitively vast number of structural possibilities are
possible [22]. In recent years our group has applied different
physical-chemical techniques to study biophysical parameters of
cryptococcal PS, including static and dynamic light scattering,
viscoelastic properties analyses and high-resolution microscopy
[23–27]. These approaches have produced new insights into the
relationship between capsule structure and function. To better
understand what is unique and what is shared among cryptococcal
capsules we analyzed the capsule of a non-pathogenic, environ-
mental member of the cryptococcal genus, C. liquifaciens and
compared this species PS with that of C. neoformans. C. liquifaciens
is not pathogenic for mammals and its inability to cause disease
has been attributed to a lack of thermolerance at mammalian
temperatures. However, C. liquifaciens expresses a pronounced
capsule, and thus provides a reasonable reference point for an
initial comparative study. In this study, we have employed a
combination of microscopy, physical chemistry and serology to
characterize the capsule of C. liquefaciens. Our goal is to identify
differences that could provide insight into the requirements for
capsules to contribute to pathogenicity. Our results reveal that C.
neoformans and C. liquefaciens capsules share many characteristics but
also differed in key aspects, which may be associated with the
variable ability of each species to cause disease in an animal host
and to survive in the environment.
Results
Isolation and identification of C. liquefaciens from
Achatina fulica
Fungal cells isolated from digestive tract of snails were
subcloned to purity on Sabouraud agar and analyzed by bio-
chemical and molecular biology identification methods. One
isolate, car17, was selected for in depth analysis. Molecular
identification of the car17 strain was done using two ribosomal
DNA targets. ITS-5.8 S rDNA showed 99% maximum identity
and 97% query coverage between Car17 sequence and C.
liquefaciens, Cryptococcus albidosimilis and Cryptococcus diffluens sequenc-
es. To discriminate between these three closely related species, we
used a second ribosomal target (D1–D2 region on 28 S rDNA),
which is used to analyze highly related species. Alignment of car17
sequence of this region showed 100% maximum identity and
100% query coverage with C. liquefaciens. Hence, the subtle dif-
ferences in nucleotide composition between these highly related
species allowed us to identify car17 as a C. liquefaciens (Figure 1).
On Sabouraud dextrose agar, colonies of C. liquifaciens car17
strain at 30uC were cream colored, smooth-mucoid and yeast-like
in appearance. Microscopic examination revealed a globose to
ovoid morphology with cell body diameters of 3.562.2 mm (data
not shown). Yeast cells were cultivated in minimal media at 30uC,
washed with PBS and suspended in India ink for microscopic
evaluation. Both C. neoformans and C. liquefaciens produced large
capsules (Figure 2). C. liquefaciens cells expressed very large
capsules, which manifested different zones of density (Figure 2B).
Regions of stronger staining were closer to the cell wall, while
capsular areas with higher degrees of permeability to India ink
were distributed into the periphery of the capsule. In contrast to C.
neoformans and C. gattii [27–29], the C. liquefaciens capsule showed
poorly defined borders. The capsule sizes were similar between the
two species, with C. neoformans having an average radius of
5.661.3 mm and C. liquefaciens 5.161.2 mm (P value.0.05).
Physiological tests of car17 strain revealed a lack of tube germ
formation at 30uC, no urea hydrolysis, and there was no growth in
cycloheximide medium and at either 4 or 37uC. No pigmentation
was observed in C. liquefaciens cells after incubation with L-dopa for
20 days, suggesting that unlike C. neoformans this specie made no
melanin. However, the growth dynamics of car17 in minimal
media at 30uC were nearly indistinguishable from those of C.
neoformans H99 strain (Figure 1C).
Compositional analysis of exo- and capsular-PS from
C. liquefaciens
The existence of a capsular network in C. liquefaciens suggested
that methods used for the isolation of capsular components in
C. neoformans might be applicable to study the capsule of this
environmental yeast. Therefore, C. liquefaciens and C. neoformans
yeast cell cultures in medium were subjected to supernatant
filtration to isolate exo-PS and DMSO to extract capsular-PS for
subsequent monosaccharide determinations. As described for C.
neoformans, ultrafiltration of C. liquefaciens supernatants resulted in
the formation of an easily collectable polysaccharide gel on the
filter membrane.Carbohydrate determinations for three different
extractions according to the method of Dubois revealed that
concentration of exo-PS from cultures of C. liquefaciens and C.
neoformans at similar cell densities was 8.561.3 and 9.160.9 mg/
ml, respectively (P value.0.05). DMSO extracts from whole cells
revealed similar PS concentrations (5.461.3 mg/ml for C.
liquefaciens and 4.960.6 mg/ml for C. neoformans; P value.0.05).
These measurements indicated that both species produced
approximately the same amount of both PS forms.
As expected, the C. neoformans DMSO extract (capsular-PS)
revealed the presence of mannose, xylose and glucuronic acid, the
components of criptococal polysaccharide (Figure 3 Table 1).
Glucose was also detected in this fraction, which has been
previously described in C. neoformans capsular-PS. C. liquefaciens PS
fractions had more glucose compared to C. neoformans (33.5% vs
16.0%,). In contrast, C. liquefaciens fractions had lower concentra-
tions relative to C. neoformans of glucuronic acid (2.6% vs 7.0%) and
galactose (5.2% vs 2.0%). Interestingly, C. liquefaciens also had trace
amounts of N-acetylglucosamine (0.5%). Similarly, in comparing
exo-PS fractions from the two species, C. neoformans had increased
amounts of xylose (24.6% vs 38.0%,), glucuronic acid (3.2% vs
10.2%), and mannose (26.4% vs 45.1%,) (Figure 3, Table 1). C.
liquefaciens exo-PS fractions contained higher amounts of galactose
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PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e29561Figure 2. Microscopic visualization of C. liquefaciens and C. neoformans capsules and growth profile. Panel A) India ink stain of C. neoformans
cells. Panel B) Counterstaining of C. liquefaciens with India ink. Panel C) Growth curves of C. neoformans and C. liquefaciens at 30uC in minimal media.
doi:10.1371/journal.pone.0029561.g002
Figure 1. Alignment of ribosomal region D1/D2, in 28 S rDNA, between C. liquefaciens strain Car17 and related species.
doi:10.1371/journal.pone.0029561.g001
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absent in the exo-PS fraction from C. liquefaciens.
Physical chemical and hydrodynamic properties of
exo- and capsular-PS
For the systematic analysis of the properties of the C. liquefaciens
PS, a number of physical chemical parameters were evaluated.
Average molecular weight and radius of gyration determinations
were performed by static light scattering analysis of exo- and
capsular-PS samples. Analysis of Exo-PS revealed a Mw of
(1.0460.69)610
6 g/mol and Rg of 222684 nm. Capsular-PS
showed an MW of (1.0560.29)610
8 g/mol and Rg of 1916
32 nm. Hydrodynamic properties of C. liquefaciens PS were
calculated from dynamic light scattering measurements. Exo-PS
had a hydrodynamic radius (Rh) of 145.9 nm and a diffusion
coefficient of 1.68610
28 cm
2/s. Capsular-PS presented an Rh of
186.39 nm and diffusion coefficient of 1.32610
28 cm
2/s. Size
distribution of PS fibers showed significant differences between
exo- and capsular-PS (Figure 4A and B). By combining results
from SLS and DLS we calculated the shape factor (r)o fP S
fractions from C. liquefaciens. The r of a polysaccharide is the ratio
of Rg to Rh and is a measure of the degree of branching of a
molecule. C. liquefaciens capsular-PS showed a r of 1.03 and exo-PS
a value of 1.521. PS fractions obtained under the same conditions
from C. neoformans demonstrate values of 0.42 (exo-PS) and 0.28
(capsular-PS).
Zeta potentials of PS fractions were measured for C. liquefaciens
and compared with C. neoformans. C. liquefaciens exo- and capsular-
PS showed zeta potential averages of 212.8765.95 mV and
219.1665.17 mV, respectively (Figure 5). Zeta potential, mobility
and frequency shift were significantly different in both fractions
(P value=0.01). For C. neoformans, the average zeta potentials for
both exo- and capsular PS were negative, being less than 230 mV
under the same conditions [25,30]. The smaller content of
glucuronic acid in the C. liquefaciens PS in comparison with the
C. neoformans sample probably accounts for these differences.
Viscosity and elastic properties of PS fractions
Young’s modulus of capsular-PS of C. liquefaciens was deter-
mined using an optical tweezers system following the theoretical
model previously described [26]. This assessment was simplified
since the capsule sizes both yeast species were statistically similar.
Young’s modulus (E) values of C. liquefaciens PS capsule were
8669 Pa, which were 2.5-fold higher than for C. neoformans
(Figure 6A, P value,0.01).
The viscosities of C. neoformans and C. liquefaciens capsular and
exo-PS were determined using the diffusion coefficient of beads
coated with a PS aqueous solution (1 mg/ml) in an optical
tweezers system and following the procedures previously described
elsewhere (Figure 6B) [25,30]. For C. liquefaciens, the capsular PS
viscosity value was 1361 cPoise, which was 8-fold higher than C.
liquefaciens exo-PS viscosity value (1.560.3 cPoise; P value,0.01).
Figure 3. Monosaccharide composition of capsular and exo-PS of C. liquefaciens and C. neoformans. Xyl (Xylose), GlcA (Glucuronic acid),
Man (Mannose), Gal (Galactose), Glu (Glucose) and GlcNAc (N-acetylglucosamine).
doi:10.1371/journal.pone.0029561.g003
Table 1. Monosaccharide composition for C. liquefaciens and C. neoformans PS.
Capsular-PS Exo-PS
C. neoformans C. liquefaciens C. neoformans C. liquefaciens
Xylose 32.3 28.8 38.0 24.6
Glucuronic acid 7.0 2.6 10.2 3.2
Mannose 48.0 29.8 45.1 26.4
Galactose 2.0 5.2 5.0 5.9
Glucose 16.0 33.5 2.0 39.9
N-acetylglucosamine NP 0.5 NP NP
Values are percentage of mole. NP not presence.
doi:10.1371/journal.pone.0029561.t001
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cPoise, almost 10-fold lower than C. neoformans exo-PS viscosity
value (2564 cPoise; P value,0.01). When both yeast species were
compared, capsular-PS viscosity for C. liquefaciens was 5-fold higher
than for C. neoformans. On the other hand, Exo-PS viscosity for C.
liquefaciens was 16-fold lower than for C. neoformans. Differences
between similar PS fractions in the two were statistically different
(P values,0.01).
Antigenic and chemical composition of C. liquefaciens
capsule
Staining of yeast cells with Uvitex revealed that the distribution
of cell wall chitin in C. liquefaciens was similar to that previously
observed for C. neoformans [31–32] (Figure 7A–C). Since GC-MS
analysis revealed the presence of the GXM building units in C.
liquefaciens samples, we hypothesized that yeast cells or their soluble
fractions could be recognized by antibodies raised to C. neoformans
GXM. These antibodies, in fact, were previously demonstrated to
cross-react with different fungi [33–34]. Monoclonal antibody
(mAb) 18B7 was selected for initial tests, since it reacts with
different GXM motifs of all C. neoformans and C. gattii serotypes [3].
Capsular structures of C. liquefaciens were recognized by mAb18B7
(Figure 7B, C, and G), suggesting the presence of common
capsular epitopes. The similarities in the capsular domains of
C. neoformans and C. liquefaciens were further confirmed by the fact
that a C. neoformans acapsular mutant was able to incorporate
mAb18B7-reactive components from exo-PS of C. liquefaciens onto
the cell surface (Figure 7E) in a manner similar to that observed
with the incorporation of C. neoformans exo-PS onto this acapsular
strain (Figure 7F).
The detection of N-acetylglucosamine in DMSO extracts of C.
liquefaciens capsule by GC-MS led us to evaluate the location of this
sugar in the capsule. N-acetylglucosamine has previously been
suggested to connect the cell wall to capsular components in C.
neoformans [31–32]. Staining of yeast cells with WGA revealed that
b1,4 N-acetylglucosamine oligomers are abundant in budding
sites, as described for C. neoformans (Figure 7G–I). Surprisingly, the
lectin also reacted with the entire capsular surface in C. liquefaciens
yeast cells. In contrast, WGA stains in a localized manner in C.
neoformans, primarily at regions of budding [32].
Serological properties of C. liquefaciens PS fractions
To further assess the capacity of C. liquefaciens to bind mAbs
raised to C. neoformans PS, we measured the dissociation constants
for PS-mAb reactions with well characterized mAbs to C.
neoformans GXM by ELISA [35–36]. The binding curves of
IgG1 18B7, (Figure 8A), IgM 13F1, (Figure 8B) and IgM 2D10
(Figure 8C) were similar for PS from both species. The dissociation
constants for the three different mAbs did not differ significantly
for C. liquefaciens and C. neoformans PS samples (Table 2), suggesting
that both extracts have comparable antigenic density for the
epitopes recognized by these mAbs.
Different outcomes after phagocytosis of C. neoformans
and C. liquefaciens by environmental amoebae
A primary function of C. neoformans capsular polysaccharides is
protection against phagocytosis and killing by animal and
environmental phagocytes [37–43]. C. liquefaciens and C. neoformans
exist in environments in which they are likely interacting with
predator amoebae. Developing resistance mechanisms to survive
predation may facilitate survival within mammalian hosts (e.g.
environmental predators serving as a ‘‘boot camp’’ for environ-
mental fungi [3]. Consequently, we evaluated the capacity of
Acanthamoeba castellanii to phagocytosis and kill C. neoformans and C.
liquefaciens, Yeast cells from both species were phagocytosed at
similar rates by amoebae (Figure 9A). However, the survival of
intracellular C. liquefaciens yeast cells was significantly less
compared to C. neoformans at 30uC (45% vs 79%. P Value,0.01;
Figure 4. Physical properties of capsular and exo-PS from C. liquefaciens obtained by DLS. Panel A and B show size distribution of PS fibers
capsular and exo-PS samples, respectively.
doi:10.1371/journal.pone.0029561.g004
Figure 5. Zeta Potential of exo- and capsular-PS from C.
liquefaciens. The charges of the different C. liquefaciens PS forms were
significantly different (P Value,0.01 calculated by Student’s T test (two-
tailed)).
doi:10.1371/journal.pone.0029561.g005
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by amoeba cells compared to the pathogenic yeast cells.
Discussion
Many of the virulence factors required for pathogenicity in
mammals are also important for fungal survival during inter-
actions with environmental predators (reviewed in [44]). The PS
capsule of C. neoformans is associated with the capacity of the
fungus to cause disease in mammals, but similar structures are
also found on environmental Cryptococcus species, which are sapro-
phytic or normal flora of small animals. While studying the giant
snail Achatina fulica microbiota, we recovered several yeast species,
including C. liquefaciens. C. liquefaciens is a member of Cryptococcus
genus, but there are no reported cases of human disease by
this species. Hence, we used C. liquefaciens as a non-mammalian
Figure 6. Elastic and viscosity properties of C. liquefaciens polysaccharide. Panel A) Young modulus (E) of C. neoformans and C. liquefaciens
capsular-PS demonstrates significant differences in their elastic properties (*** P value,0.01 calculated by Student’s T test (two-tailed)). Panel B)
Viscosity values for C. neoformans and C. liquefaciens capsular and exo-PS. The differences between exo- and capsular-PS in C. neoformans and C.
liquefaciens were statistically significant (P value,0.01 calculated by Student’s T test (two-tailed)). Also, the differences between PS types for both yeast
species were statistically significant (P value,0.01 calculated by Student’s T test (two-tailed)).
doi:10.1371/journal.pone.0029561.g006
Figure 7. Surface architecture of C. liquefaciens. Panel A) Uvitex staining (blue) of C. liquefaciens strain showing chitin distribution at the cell wall.
Panel B) Staining of C. liquefaciens cell with mAb 18B7 showing that the antibody raised to C. neoformans GXM cross reacts with C. liquefaciens
components. Panel C) Merge of panels A and B. Panel D) Light microscopy of acapsular C. neoformans cap67 cells. Panel E) Exo-PS from C. liquefaciens
attaching to an acapsular C. neoformans mutant with the PS labeled with mAb 18B7-FITC. Panel F) Incorporation of C. neoformans (control) exo-PS by
acapsular C. neoformans cells with labeling of PS by mAb 18B7-FITC. Panel G) C. liquefaciens labeled with 1 mAb 8B7-FITC Panel H) C. liquefaciens
stained with WGA-rhodamine. Panel I). Merge of G and H with C. neoformans labeled with mAb 18B7 (green fluorescence) and WGA (red
fluorescence).
doi:10.1371/journal.pone.0029561.g007
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features of the PS from C. liquefaciens with PS from C. neoformans.
C. liquefaciens produced a PS capsule that was similar to the
capsule of C. neoformans when visualized by light microscopy. C.
liquefaciens secreted large amounts of PS into the media. Isolated
capsular and exo-PS from C. liquefaciens contained similar
monosaccharide composition when determined by GS-MS as C.
neoformans PS fractions, but the ratios of the monosaccharides were
different in the two species. Glucose was also detected in all
fractions, which may reflect the co-extraction of glucans, which are
frequently found in DMSO extracts of C. neoformans [25]. The
amount of glucose was higher in C. liquefaciens PS fractions.
N-acetylglucosamine was detectedby GS-MS in C. liquefaciens
capsular and it was also labeled by fluorescent lectin, indicating
that this compound is a component of C. liquefaciens capsule. Since
the two Cryptococcus species contained the same monosaccharides,
we hypothesized that C. liquefaciens cells or their soluble fractions
could be recognized by antibodies raised to C. neoformans GXM.
These antibodies are known to cross-react with different fungi
[33,34]. Similarities in the overall Kd for the mAbs and the PS
fractions from both yeast species suggested that the extracts were
recognized with comparable affinities by antibodies to GXM. The
similarities in the capsular domains of C. neoformans and C.
liquefaciens were further highlighted by the fact that a C. neoformans
acapsular mutant was able to incorporate mAb18B7-reactive
components from C. liquefaciens onto the cell surface, suggesting
similarities in the mechanisms of capsule anchoring to the cell
wall.
Given that the monosaccharide compositions were similar be-
tween these two species and that they shared antigenic deter-
minants, we hypothesized that differences in physical parameters
could generate differences in interactions with phagocytes. Macro-
Figure 8. Binding of monoclonal antibodies to C. liquefaciens polysaccharide. Serological reactivity of C. liquefaciens PS with antibodies 18B7
(panel A; IgG1), 13F1 (panel B; IgM) and 2D10 (panel C; IgM) are shown. C. neoformans PS was used in control systems.
doi:10.1371/journal.pone.0029561.g008
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differences between the species. In particular, the shape factor
values provide important knowledge about differences in the
degree of branching of PS molecules. The r of capsular and exo-
PS in C. neoformans were values characteristic of linear molecules.
However, the r of both fractions on C. liquefaciens PS were values
typical of linear PS [23]. Similarly, the zeta potential, Young
modulus and viscosity values of C. liquefaciens PS were consistent
with linear structures. In contrast, these measurements in C.
neoformans correspond to PS with branched structures [23].
Studies have established the potential of physical chemical
properties of C. neoformans and C. gattii PS fractions to modulate the
host response [23–24]. The degree of PS branching can influence
the biological properties of C. neoformans [23]. Therefore, we
hypothesized that C. liquefaciens’ linear PS capsule would result in
different interactions with A. castellanii compared to amoebae
interacting with the highly branched capsule of C. neoformans.
Interestingly, both species were phagocytosed at similar rates.
However, the intracellular survival of C. neoformans was significantly
greater than that of C. liquefaciens. Although we cannot determine
the extent to which the capsule of C. liquefaciens contributes to the
reduced survival after phagocytosis relative to C. neoformans, we can
state that the C. liquefaciens PS is not sufficient to protect the fungus
from predation.
The capsule of C. neoformans benefits the fungus during
interactions with animal phagocytes and amoeboid predators
[40,41,44]. The ability of different cryptococcal PS to promote
survival during interactions with phagocytes may be a key
determinant for the ability of fungal cells to persist and cause
disease in mammalian hosts, differentiating opportunistic patho-
gens from exclusively environmental microbes. Here we demon-
strate that C. liquefaciens, an environmental yeast, produces a PS
capsule that is similar to that produced by the pathogenic
members of the Cryptococcus genus in many aspects, but the
capsular and exo-PS manifest significant structural differences
such that they are less efficient in protecting the yeast. Although
the virulence barrier for C. liquefaciens is almost certainly related to
its inability to tolerate mammalian temperatures, our findings
reveal that it also lacks melanin and has a less effective, linear
capsule. Hence, morphologically similar capsules by light
microscopy can have major differences in physical and protective
properties.
Materials and Methods
Yeast strains
The strain of C. liquefaciens used in this study was obtained as
described below. C. neoformans H99 strain was used as a reference
control in all assays. Fungal cells were maintained on Sabouraud
solid medium at 30uC. For capsule induction, yeast cells were
grown at 30uC in minimal medium (16 mM of glucose, 10 mM of
MgSO4, 29.4 mM of KH2PO4 and 13 mM of glycine, pH 5.5).
Incubation times depended on the experiment performed. For
each experiments, C. neoformans and C. liquefaciens were growth
under the same conditions.
Isolation of C. liquefaciens
C. liquefaciens was isolated from the snail Achatina fulica. Briefly,
five different animals were captured from the campus of the
University of Rio de Janeiro at different periods of time.
Approximately 3 ml of digestive juice were collected from the
crop and stomach after the animals were anesthetized by
immersion into 0.4 mg/mL of sodium pentobarbital for 8 h as
Figure 9. Phagocytosis assays of fungal cells by Acanthamoeba castellanii. Panel A) Profiles of interaction of FITC-labeled C. liquefaciens at
30uC with Acanthamoeba castellanii as determined by flow cytometry. In red, fluorescence population of C. neoformans cells in amoebae. In blue,
fluorescence population of C. liquefaciens cells in amoebae. In black, non-fluorescence control amoebae. Panel B) Fungal survival (CFU counts) of
yeast cells after interaction with amoebae is shown for C. liquefaciens and C. neoformans at 30uC. All experiments were done in triplicates and
Student’s T test (two-tailed) was carried for statistical studies.
doi:10.1371/journal.pone.0029561.g009
Table 2. Dissociation constants (Kd) after binding of mAbs to
cryptococcal PS.
PS sample Kd±Std.error
18B7-Cn
1 0.09960.014
18B7-Cl
2 0.10260.012
13F1-Cn 1.36660.217
13F1-Cl 1.23960.123
2D10-Cn ND
2D10-Cl ND
1Cn: C. neoformans.
2Cl: C. liquefaciens.
ND: Not determined.
doi:10.1371/journal.pone.0029561.t002
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diluted in phosphate buffered saline (PBS). A 100 mL volume was
plated on Sabouraud agar media and incubated at 30uC for 72 h.
Pure cultures were obtained after repeated sub-culturing on
Sabouraud agar media. An isolate, named car17, was verified as C.
liquefaciens and selected for use in all subsequent studies.
Biochemical and molecular identification
Growth curves. Car17 yeast cells were grown in minimal
medium for 7 d at 30uC and cell density was measured every 6 h.
C. neoformans cells were used as controls. Optical density was
measured at 540 nm.
Urea degradation. C. liquefaciens and C. neoformans yeast cells
were grown for 48 h at 30uC in a differential medium that tests the
ability of an organism to produce urease by the hydrolysis of urea
to ammonia and carbon dioxide. Candida albicans ATCC 10231
was used as negative control.
Growth on cycloheximide medium. H99 and car17 yeast
cells were grown in Sabouraud media supplemented with 0.01% of
cycloheximide for 5 d at 30uC.
Melanization assays. For the in vitro melanization assay,
H99 and car17 yeast cells were streaked on chemically defined
minimal medium (15 mM glucose, 10 mM MgSO4, 29.4 mM
KH2PO4, 13 mM glycine and 3 mM thiamine, pH 5.5), with and
without 1 mM L-DOPA (Sigma-Aldrich), and incubated in the
dark for 20 days at 30uC. Plates were examined daily to monitor
growth and pigment production.
Germ tube formation. Production of germ tube formation
was tested by incubation of car16 yeast cells in horse serum at 30
and 37uC for 2 hours.
Molecular identification. Genomic DNA was extracted and
purified from yeast phase car17 cells by phenol/chloroform/
isoamyl alcohol as described [46]. For partial sequencing, primers
UNI1 (59-GTCAAACTTGGTCATTTA-39) and ITS4 (59-
TCCTCCGCTTATTGATATGC-39), targeting the conserved
regions of 18 S and 28 S rDNAs [47], respectively, were used for
amplification. To confirm the result and differentiate between
closely related species, the region D1/D2 in 28 S rDNA was
analyzed using the primers NL1 (59-GCATATCAATAAGC-
GGAGGAAAAG-39) and NL4 (59TCCTCCGTCTATTGAT-
ATGC-39). Briefly, we used 5 mlo f1 0 6 PCR buffer, 1.5 ml
of magnesium chloride (50 mM), 0.4 ml of a deoxynucleoside
triphosphate mixture (10 mM each dNTP), 0.8 ml of each primer
(40 pmol of each primer), and 0.5 ml (2.5 U) of PlatinumHTaq
DNA Polymerase (Invitrogen, Brazil) in a volume of 50 ml.
Amplification consisted of an initial denaturation at 94uC for
4 min; 30 cycles of denaturation at 94uC for 30 s, annealing at
55uC for 30 s, and extension at 72uC for 1 min; and a final
extension at 72uC for 4 min; a PCR system thermal cycler (Biorad,
USA) was used. Negative control reactions without any template
DNA were carried out simultaneously. Automated sequencing was
done using the Sequencing Platform at Fundac ¸a ˜o Oswaldo Cruz -
PDTIS/FIOCRUZ, Brazil. Sequences from both strands were
generated, edited with the Sequencher ver. 4.6 software package
(Genes Codes Corporation, USA), and aligned by means of the
Mega version 4.0.2 software. The sequences of our strain were
compared by BLAST (Basic Local Alignment Search Tool- NIH)
with sequences available from NCBi GenBank.
Capsule visualization and size measurements by India-ink
counter staining
Yeast cells were visualized with an optical microscope (Leica
DM5000B, Leica Microsystem, Mannheim, Germany) after
suspension in India ink. The capsule size of 100 cells was
measured in ImageJ 1.40 g software (http://rsb.info.nih.gov/ij/);
National Institutes of Health (NIH), Bethesda, MD).
Isolation of exopolysaccharides (exo-PS) from culture
supernatants by filtration
Based on its ability to self aggregate, PS that accumulated in
culture supernatants (exo-PS) were isolated by ultrafiltration using
an Amicon (Millipore, Danvers, MA) ultrafiltration cell (cu-
toff=100 kDa) as described [30]. The final PS solution was
lyophilized and the dry PS mass determined.
Extraction of capsular polysaccharide (capsular-PS)
components with dimethyl sulfoxide (DMSO)
Capsular PS were isolated from yeast cells as described [48].
Briefly, yeast cells were suspended in 15 mL of DMSO and
incubated for 30 min at room temperature. DMSO supernatant
was collected and then dialyzed extensively against water for 3 d at
room temperature. The final PS solutions were lyophilized and the
dry PS mass determined.
Glycosyl composition of PS
PS fractions were dissolved in methanol/1 M HCl and
incubated at 80uC for 18 h. Samples were per-O-trimethylsilylated
by treatment with Tri-Sil (Pierce) for 30 min at 80uC. The per-O-
TMS derivatives were analyzed by gas chromatography coupled
to mass spectrometry (GC-MS) as described [25].
Labeling of C. liquefaciens with probes for the fungal cell
surface
Yeast cells (10
6) were suspended in 4% paraformaldehyde
cacodylate buffer (0.1 M, pH 7.2) and incubated for 30 min
at room temperature. Fixed yeast cells were washed twice in
PBS and incubated in 1% bovine serum albumin in PBS (PBS-
BSA) for 1 h at room temperature. The cells were washed
again and incubated for 1 h at room temperature in the presence
of mAb 18B7 (1 mg/ml). The mAb 18B7 is a mouse IgG1 with
high affinity for GXM of different cryptococcal serotypes [3].
After washing in PBS, the cells were incubated with 25 mM
Uvitex2B for 1 h at room temperature. Uvitex2B (Polyscience
Inc, Warrington, PA) binds to chitin (a polymer of N-Acetyl-D-
Glucosamine) in fungal walls. After washing in PBS, the cells
were finally incubated with a fluorescein isothiocyanate (FITC)
labeled goat anti-mouse IgG (Fc specific) antibody (Sigma) for
1 h at room temperature. In some systems, yeast cells were also
stained with the lectin WGA, with known affinity for b1,4 N-
acetylglucosamine (GlcNAc) oligomers. Cells were suspended in
100 mlo fa5mg/ml solution of the Alexa Fluor 594 conjugate
of WGA (Molecular Probes) and incubated for 30 min at
37uC. Cell suspensions were mounted over glass slides and
analyzed with a Leica DM5000B (Leica Microsystem, Mann-
heim, Germany) fluorescence microscope. Images were pro-
cessed using ImageJ.
Polysaccharide binding by acapsular cells
Acapsular C. neoformans yeast cells (strain Cap67, 10
6 cells) were
suspended in 100 ml of culture supernatants (4 day cultures) from
C. neoformans or C. liquefaciens. PS in supernatants was normalized
to10 mg/ml. The suspension was incubated for 12 h at 25uC and
extensively washed with PBS. Control systems consisted of Cap67
cells incubated with sterile medium. For immunofluorescence with
mAb 18B7, the cells were fixed with 4% paraformaldehyde and
prepared as described above [49].
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mass (Mw) and radius of gyration (Rg) by Static Light
Scattering (SLS)
PS solutions were prepared by solubilizing lyophilized polysac-
charide in sterile-filtered, degassed ultra-pure water. All samples
were passed through an in-line 0.8 mm syringe filter prior to light
scattering analysis to eliminate large aggregates, dust and reduce
extraneous sources of refracted or scattered light. Differential
refractometry was done using a 620 nm laser source (BI-DNDC;
Brookhaven Instruments Corp., Holtsville, NY) to measure the
change in refractive index as a function of concentration (dn/dc)o f
the PS samples. Molecular masses and radius of gyration were
determined at 25uC by multi-angle laser light-scattering in a
molecular weight analyzer (BI-MwA, Brookhaven Instruments
Corp., Holtsville, NY) using a 675 nm laser source, as described
[25,50]. The Mw and Rg were determined using Berry plots,
which is more accurate for large molecular mass polymers.
Effective diameter and hydrodynamic radius of PS
samples analyses by Dynamic Light Scattering (DLS)
The effective diameter and the polydispersity of PS preparations
were measured by Quasi-Elastic Light Scattering (QELS) in a
90Plus/BI-MAS Multi Angle Particle Sizing analyzer (Brookhaven
Instruments Corp., Holtsville, NY) as described [27]. PS solutions
were prepared as described above. Measurements were done at
25uC. The multimodal distributions of particle size diameter were
generated by a Non-Negatively constrained Least Squares
algorithm (NNLS) based on the intensity of light scattered by
each particle. All PS samples were analyzed under the same
conditions.
Zeta Potential measurements
Zeta potential (Z), particle mobility and shift frequency of
polysaccharide samples were calculated in a Zeta potential
analyzer (ZetaPlus, Brookhaven Instruments Corp., Holtsville,
NY) as described [25]. Measurements were done at 25uC.
Binding of monoclonal antibodies (mAbs) to PS in
polystyrene plates
Binding of mAbs to the different PS fractions was evaluated by
ELISA [35]. Briefly, polystyrene plates were coated with 1 nM PS
samples, calculated from the molar concentrations previously
determined by the molecular mass measurements. The plates were
blocked with PBS containing 1% of bovine serum albumin. The
mAbs to PS 18B7 (IgG1), 2D10 (IgM) or 13F1 (IgM) [35–36] were
then added to the plates, followed by detection of antibody binding
to PS using alkaline phosphatase-labeled secondary antibodies.
Colored reactions were developed after the addition of p-
nitrophenyl phosphate (p-NPP) solutions (Sigma, St. Louis, MO)
and quantitative determinations performed by absorbance mea-
surement at 405 nm. All incubations were carried at 37uC for 1 h.
Determination of Bmax and Kd was calculated with GraphPad
Prism 5.02 by fitting only total binding and assuming that the
amount of nonspecific binding is proportional to the concentration
of PS. Bmax is the maximum specific binding and Kd is the
equilibrium binding Constant meaning the PS concentration
needed to achieve a half-maximum binding at equilibrium.
Measurements of viscosity and elastic properties of
C. liquefaciens PS using optical tweezers
Young’s modulus value of C. liquefaciens capsular-PS was
determined using Glass-bottom dishes coated with 10 mg/mL of
mAb 18B7 and incubated for 1 hour at 37uC. Suspensions of 10
4
yeast cells in PBS were added to the plates and incubated for 1 h
at room temperature. After washing with PBS to remove non-
adherent cells, polystyrene beads were added to the plate and the
samples were placed in the optical tweezers system. Young’s
modulus values were determined following the theoretical model
previously stated [26]. H99 C. neoformans cells were used as
controls. Viscosity of Capsular-PS and Exo-PS in aqueous solution
at 1 mg/mL solution was determined using an optical tweezers
assays as previously described [30,51]. C. neoformans capsular-PS
and exo-PS samples were similarly measured.
Phagocytosis assays in amoeba
For interaction of yeast cells with A. castellanii, amoeba cells were
grown in peptone yeast extract glucose broth (PYG; ATCC
medium 354). A. castellanii cells were plated in 24-well plates at the
density of 10
6 cells/ml and incubated 1 h at 28uC for adherence to
the plastic surface. Suspensions of FITC-labeled C. neoformans and
C. liquefaciens cells were then added at a density of 1610
6 cells/ml
and the co-cultures were incubated for 1 h at 28uC. Infected
amoebae were removed from the plates by scraping for flow
cytometry analysis on a FACSCalibur (BD 298 Biosciences, San
Jose, CA) flow cytometer. Data were processed with CellQuest
(BD Biosciences) and WinMDI (Salk Flow Cytometry). The index
of infection was determined as the percentage of fluorescent to
non-fluorescent amoeba cells. To discriminate adhered and
internalized fungi, infected amoebas were treated for 10 min at
25uC with Trypan blue (200 mg/ml), which quenches the
fluorescence of external FITC-labeled fungal cells. Control
preparations consisted of amoebae that were not exposed to yeast
cells or of amoebae that were infected with unstained yeast (data
not shown).
For determination of fungal killing after interaction with A.
castellanii, amoeba cells were distributed in 96-well plates (10
5 cells
per well) and interactions between these amoebae and fungal cells
were analyzed using the conditions described above. Amoebae
were then lysed with sterile cold water and the resulting suspension
plated onto Sabouraud agar plates. After 48 h of cultivation at
room temperature, the number of colony-forming units (CFU) was
determined. All experiments were done in triplicates and Student’s
T test (two-tailed) was carried for statistical studies.
Statistical analysis
Statistical analyses were carried in Bi-ZPMwA Zimm Plot
Software (Brookhaven Instruments Corp., Holtsville, NY) for Mw,
Rg and A2. 90Plus/BI-MAS Software was used for effective dia-
meter, polydispersity and diffusion coefficient parameters (Brook-
haven Instruments Corp., Holtsville, NY). Zeta Plus software was
used for Zeta Potential, Mobility and Frequency Shift data
(Brookhaven Instruments Corp., Holtsville, NY). Plots, curve fits,
and statistical analysis were performed using GraphPad Prism
version 5.0a, GraphPad Software, San Diego California USA.
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